Blood Purification Center of Hainan General Hospital, Hainan Affiliated Hospital of Hainan Medical University, No.19 Xiuhua Road, Xiuying District, Haikon City, Hianan Province, China.
Department of Cardiovascular Medicine, Sanya Peoples Hospital, West China Sanya Hospital of Sichuan University, No.558 Jiefang Road, Sanya City, Hainan Province, China.
Int Urol Nephrol. 2022 Dec;54(12):3179-3191. doi: 10.1007/s11255-022-03192-7. Epub 2022 Jun 11.
Patients with chronic kidney disease (CKD) have an associated burden of coronary artery disease, including chronic total occlusions (CTO). It is unclear how the presence of CKD affects the outcomes of CTO revascularization. Previous reviews have not taken into account all relevant published studies that examined the association of CKD with outcomes of CTO revascularization.
A systematic search was conducted using PubMed, Scopus, and Google Scholar databases for studies investigating patients with or without CKD who also had coronary chronic total occlusion undergoing revascularization procedures Statistical analysis was performed using STATA software. Effect sizes were reported as pooled relative risk (RR).
A total of 13 studies were included. CKD patients showed elevated risk of in-hospital mortality (RR 4.25, 95% CI 2.64, 6.82) and mortality at latest follow-up (RR 3.24, 95% CI 2.56, 4.11), elevated risk of major cardio or cerebrovascular events (RR 1.65, 95% CI 1.38, 1.98), major bleeding (RR 2.85, 95% CI 1.96, 4.13), and contrast-induced acute kidney injury (RR 3.06, 95% CI 1.70, 5.52). CKD patients also showed lower chances of technical success (RR 0.95, 95% CI 0.91, 1.00).
The presence of CKD increases the risk of mortality, complications and adversely affects the success of CTO revascularization. Patients with CKD undergoing revascularization should have their kidney function comprehensively evaluated and these patients should be carefully monitored.
患有慢性肾脏病(CKD)的患者存在冠状动脉疾病负担,包括慢性完全闭塞(CTO)。目前尚不清楚 CKD 的存在如何影响 CTO 血运重建的结局。既往的综述没有考虑到所有相关的已发表研究,这些研究检查了 CKD 与 CTO 血运重建结局的关系。
使用 PubMed、Scopus 和 Google Scholar 数据库系统地搜索了研究 CKD 患者或无 CKD 患者同时患有冠状动脉慢性完全闭塞并接受血运重建的研究。使用 STATA 软件进行统计分析。效应大小以汇总相对风险(RR)报告。
共纳入 13 项研究。CKD 患者的住院死亡率(RR 4.25,95%CI 2.64,6.82)和随访时的死亡率(RR 3.24,95%CI 2.56,4.11)、主要心脑血管事件(RR 1.65,95%CI 1.38,1.98)、大出血(RR 2.85,95%CI 1.96,4.13)和对比剂诱导的急性肾损伤(RR 3.06,95%CI 1.70,5.52)的风险增加,技术成功率(RR 0.95,95%CI 0.91,1.00)降低。
CKD 的存在增加了死亡率、并发症的风险,并对 CTO 血运重建的成功率产生不利影响。接受血运重建的 CKD 患者应全面评估其肾功能,并对这些患者进行仔细监测。